SCHEDULE 3Information to be included in applications for consent to market genetically modified organisms

PART IIAdditional relevant information

11

Specific instructions for carrying out monitoring and reporting to the applicant and, if required, the Secretary of State, which are consistent with Part C of Annex VII of the Deliberate Release Directive.